Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1231 to 1245 of 1330 results for heart OR cardi* OR arrythmia

  1. Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery (IPG177)

    We have moved interventional procedures guidance 177 to become HealthTech guidance 115. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  2. Digital platforms to support cardiac rehabilitation: early value assessment (HTE35)

    We have moved Health technology evaluation 35 to become HealthTech guidance 761. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  3. VA ECMO for extracorporeal cardiopulmonary resuscitation (ECPR) in adults with refractory cardiac arrest (IPG808)

    We have moved interventional procedures guidance 808 to become HealthTech guidance 765. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  4. Temperature control to improve neurological outcomes after cardiac arrest (IPG782)

    We have moved interventional procedures guidance 782 to become HealthTech guidance 710. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  5. VA ECMO for postcardiotomy cardiogenic shock in adults (IPG810)

    We have moved interventional procedures guidance 810 to become HealthTech guidance 762. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed

    Withdrawn guidance

  6. Insertion of a subcutaneous implantable cardioverter defibrillator for prevention of sudden cardiac death (IPG454)

    Interventional procedures, IPG454 - Issued: April 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 603.

    Withdrawn guidance

  7. Zio Service for detecting cardiac arrhythmias (MIB101)

    This advice has been updated and replaced by NICE healthtech guidance 562.

    Withdrawn advice

  8. Reveal LINQ insertable cardiac monitor to detect atrial fibrillation after cryptogenic stroke (MIB141)

    This advice has been updated and replaced by NICE healthtech guidance 553.

    Withdrawn advice

  9. Implantable cardioverter defibrillators (ICDs) for the treatment of arrhythmias (TA11)

    This guidance has been replaced by NICE technology appraisal guidance 95 [Replaced by NICE technology appraisal guidance 314]. 

    Withdrawn guidance

  10. Implantable cardioverter defibrillators for arrhythmias (TA95)

    This guidance has been updated and replaced by NICE technology appraisal guidance 314.

    Withdrawn guidance

  11. Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (TA696)

    This guidance has been updated and replaced by NICE technology appraisal guidance 984.

    Withdrawn guidance

  12. Cardiovascular disease: risk assessment and reduction, including lipid modification (CG181)

    This guideline has been updated and replaced by NICE guideline NG238.

    Withdrawn guideline

  13. Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease (CG172)

    This guideline has been updated and replaced by NICE guideline NG185.

    Withdrawn guideline

  14. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease (CG67)

    This guidance has been updated and replaced by NICE guideline CG181.

    Withdrawn guideline

  15. Cardiovascular disease prevention: statins for people newly diagnosed with hypertension or T2DM (IND162)

    This indicator has been updated and replaced by NICE indicator 287.

    Withdrawn indicator